PharmaTher Submits Regulatory Approval for New Ketamine Delivery System…
Ketamine Specialty Company PharmaTher Holdings Ltd. PHRRF submitted Type B Package of meetings to the FDA to discuss the remaining requirements for the KETARX on-body
Home » Submits
Ketamine Specialty Company PharmaTher Holdings Ltd. PHRRF submitted Type B Package of meetings to the FDA to discuss the remaining requirements for the KETARX on-body
VANCOUVER, BC / ACCESSWIRE / December 16, 2022 / Klondike Gold Corp. (TSXV:KG)(FRA:LBDP)(OTCQB:KDKGF) (“Klondike Gold” or the “Company”) is pleased to announce that following the
VANCOUVER, British Columbia, Sept. 22, 2022 (GLOBE NEWSWIRE) — Osino Resources Corp. OSI (FWB:RSR1) OSIIF (“Osino” or “the enterprise“) is pleased to announce that, following
A new analysis from The Schiller Kessler Group of national mortality data has found that preventable injury claimed 197,449 American lives in 2024, an average
Traffic surrounding a major stadium event can begin hours before the first spectator enters the venue and continue well after the crowd has gone home.
Every business hits a ceiling determined not by market size, competitive dynamics, or capital availability — but by the number of hours its owner can